A campaign involving 19 Visual Studio (VS) Code extensions that embed malware inside their dependency folders has been uncovered by cybersecurity researchers. Active since February 2025 but identified ...
In this post, we will show you how to create real-time interactive flowcharts for your code using VS Code CodeVisualizer. CodeVisualizer is a free, open-source Visual Studio Code extension that ...
Discover the leading code analysis tools for DevOps teams in 2025. Enhance your software development process with automated security and quality checks to mitigate risks and improve code health.
The sheer number of extensions for VS Code can be so overwhelming that even veteran users get lost searching for what they need. Let me show you how to take your coding experience to an entirely new ...
To change the execution policy to run PowerShell scripts on Windows 11 (or 10), use these steps: Open Start. Search for ...
We’ve been hearing rumors about a potential new generation of Studio Display for a while, but 2025 came and went without an announcement. But that’s about to change, as Macworld has seen evidence of a ...
January 5, 2026: We checked for new Once Human codes. What are the latest Once Human codes? There are times in all of our gaming lives when we need a little bit of help. Call it a handout, a freebie, ...
January 2, 2026: Happy New Year! We added two new Warframe codes that provide glyphs. What are the new Warframe codes? If you're on the hunt for free glyphs and cosmetics, you're in luck - we've got a ...
The current bet365 bonus code offers new users $150 in bonus bets with a $5 wager, whether they win or lose. The bonus bets can be claimed with a bet on any sport happening today, including college ...
Before you can begin to redeem SHiFT codes in Borderlands 4, you must first ensure you have signed up for SHiFT and have created a free SHiFT Account. Once you have created a free account and linked ...
Vaxcyte, Inc. (NASDAQ:PCVX) is one of the best biotech stocks to buy, according to Wall Street analysts. On December 8, the company confirmed the dosing of the first patients in its Phase 3 OPUS trial ...